Compare BMRN & OC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRN | OC |
|---|---|---|
| Founded | 1996 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 12.0B |
| IPO Year | 1999 | 2006 |
| Metric | BMRN | OC |
|---|---|---|
| Price | $59.87 | $118.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 11 |
| Target Price | $88.22 | ★ $145.27 |
| AVG Volume (30 Days) | ★ 1.7M | 958.7K |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.77 | ★ 1.50 |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | N/A |
| Revenue Next Year | $12.23 | $3.72 |
| P/E Ratio | ★ $77.32 | $79.81 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $97.53 |
| 52 Week High | $70.98 | $159.91 |
| Indicator | BMRN | OC |
|---|---|---|
| Relative Strength Index (RSI) | 31.36 | 34.29 |
| Support Level | $58.03 | $117.15 |
| Resistance Level | $60.36 | $129.58 |
| Average True Range (ATR) | 1.43 | 4.10 |
| MACD | -0.71 | -0.20 |
| Stochastic Oscillator | 9.83 | 2.58 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.